LEI 875500KLYW21WUXR5V59
etherna immunotherapies
Contract awards & public grants
Next Generation Immune Checkpoint Inhibitor for Cancer Therapy → ETHERNA IMMUNOTHERAPIES
European Commission · BE · Grant · 2025-07-10
—
Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine → ETHERNA IMMUNOTHERAPIES
European Commission · BE · Grant · 2021-02-15
€5.09M
EXpanding Platforms for Efficacious mRNA Therapeutics → ETHERNA IMMUNOTHERAPIES
European Commission · BE · Grant · 2019-07-03
€5.43M
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection → ETHERNA IMMUNOTHERAPIES
European Commission · BE · Grant · 2016-12-12
€215,000
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.